Upper Limb Evaluation in Non Ambulatory Patients With Neuromuscular Disorder

Development and Evaluation of a Clinical Test in Order Quantify Muscular Function in Upper Limb of Non Ambulatory Patients With Neuromuscular Disorder

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00993161

Acronym

ULENAP

Enrollment

174

Registered

2009-10-12

Start date

2010-01-31

Completion date

2013-05-31

Last updated

2017-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Disorders

Keywords

Neuromuscular disorders, Evaluation, Strength, Upper limb

Brief summary

The aim of this study is to evaluate different devices to quantify upper limb function (Motriplate) and strength (Myogrip, Myopinch) in non-ambulatory patients with neuromuscular disorder. Motriplate measures the ability of the patient to reproduce a repetitive movement of the wrist to push two 5cm\*5cm targets during 30 seconds. One hundred patients aged 8-30 years and 60 controls will be evaluated during twelve months (M0, M6 and M12) with theses new tools, and results will be compared to other testing, such as wrist, grip and pinch strength, taping, MFM measurement, and self evaluation of hand ability.

Interventions

DEVICEMotriplate

Number of contact couples

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

8 Years to 30 Years

Healthy volunteers

Yes

Inclusion criteria

* Confirmed neuromuscular disorder * Aged 8-30 years * Written consent * Non ambulant

Exclusion criteria

* Major cognitive impairment * Inability to stay seated one hour * Recent upper limb surgery or trauma * Treatment by steroids initiated less than 6 months before

Design outcomes

Primary

Measure	Time frame
Number of contact couples with the targets	Month 0, Day 60, Month 6, Month 12

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026